Infiltrating B-cell subtypes and associated hub genes in nasopharyngeal carcinoma identified from integrated single-cell and bulk-RNA sequencing data.
135 Background: Nasopharyngeal carcinoma (NPC) is associated with lymphocyte infiltration; however, the majority of research on NPC has focused on the role of T cells, with relatively little known about the roles of B cells and their subtypes. Therefore, we evaluated the prognostic value of CD20+ B cell density and B-cell subtypes along with their functional enrichment and hub genes in NPC. Methods: The prognostic value of CD20+ B-cell density for distant metastasis-free survival (DMFS), overall survival (OS), and progression-free survival (PFS) was explored by immunohistochemistry using multivariate analysis. Transcriptomic expression data from Gene Expression Omnibus (GEO) datasets were analyzed to identify B-cell subtypes and their functional enrichment in NPC tissues. Pseudotime trajectory analysis was performed to evaluate the B-cell differentiation trajectory and hub genes were identified using Cytoscape software. Results: Patients with NPC exhibiting a high infiltrating density of CD20 + B cells showed significantly better 5-year DMFS, OS, and PFS compared to those of patients with a low infiltrating density. Naïve B cells, switched memory B cells, exhausted B cells, and plasma cells were identified as key B-cell subtypes infiltrating NPC tumors, with naïve B cells showing the highest infiltration levels associated with a better prognosis. Naïve B cells were closely associated with immune pathways and the hub genes were typical markers for T and B cells. Conclusions: A high infiltrating density of B cells showed strong prognostic value in patients with NPC. Naïve B cells may play an important role in tumor immunity for NPC.
Authors
- Tianzhu Lu (ORCID: https://orcid.org/0000-0002-1524-7909)
- Zhiliang Liu (ORCID: https://orcid.org/0000-0001-7105-7950)
- Xiaopeng Xiong (ORCID: https://orcid.org/0000-0002-5696-2271)
- Fangyan Zhong (ORCID: https://orcid.org/0000-0002-0766-5721)
- Lin Zhang (ORCID: https://orcid.org/0000-0003-3825-4973)
- Junjun Chen (ORCID: https://orcid.org/0000-0002-1549-7991)
- Xiaochang Gong
- Chunhong Guan
- Jingao Li (ORCID: https://orcid.org/0000-0002-0389-7576)
Institutions
- Nanchang University (CN)
- Jiangxi Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-08-10
- DOI
- https://doi.org/10.1200/jco.2024.42.23_suppl.135
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00